National Lipid Association

Industry Innovations

Health EN ↓ 4 episodes

The National Lipid Association is proud to host Industry Innovations , a podcast series dedicated to showcasing the latest advancements in lipidology. Designed for clinicians, this series offers exclusive insights into cutting-edge science, research breakthroughs, and emerging therapies shaping the future of lipid management.

Author

National Lipid Association

Episodes

Episode 4: Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion 30.09.2025 28:59

In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatmen...

Episode 3: Autoimmune Statin Induced Myopathy: What Everyone Needs to Know 15.07.2025 35:46

In this episode of Industry Innovations , host Dr. Alan Brown sits down with Dr. Lisa Christopher-Stine, a leading expert in autoimmune muscle disease, to explore the often-overlooked condition of statin-induced autoimmune myopathy. Together, they discuss how to recognize, diagnose, and manage this rare but serious complication, offering key takeaways for clinicians prescribing statins and managin...

Episode 2: From Innovation to Impact: The RNA Interference Era Begins 11.06.2025 38:41

Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.

Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO 26.11.2024 42:02

In this episode of Industry Innovations , host Dr. Peter Jones is joined by Dr. Guy Mintz to explore an exciting advancement in cardiovascular care: LODOCO, a low-dose colchicine developed by Agepha Pharma. Backed by robust clinical trial data, LODOCO is an FDA-approved therapy targeting inflammation as a novel approach to reducing the risk of heart attacks. Learn how inflammation contributes to...